Expansion
PharmSight opens a European hub in Zug
A base closer to European clients, with Conversity at the centre of the launch.
Analytics, evidence, intelligence, and AI — brought together so commercial teams can act with confidence.
Expansion
A base closer to European clients, with Conversity at the centre of the launch.
United States
A US subsidiary and strategic hub as the global footprint grows.
AI products
Cintel, Conversity, IntelliSight, and PharmLens now sit together.
“Most commercial questions are lost between the numbers and the decision. Our work is to close that gap — and leave the tools behind so the next answer comes faster.”
PharmSight leadership team
We combine technology, business, and pharma expertise to take on the commercial questions that matter most to brand, access, and leadership teams.
Guided by the realities of the market, we turn findings into plans a cross-functional team can defend.
Understand
Market sizing, landscapes, and patient analytics that show where the opportunity really is.
Our analytics
Decide
Forecasts, HTA support, and value dossiers that let leaders choose and defend a direction.
Our evidence work
Act
AI products and suites that keep field, brand, and access teams moving after the project ends.
Our productsFive practices. Choose one to see what it covers.
Field force, marketing, access, and patient data turned into the next action.
Evidence that shows the value of a therapy to payers, HTA bodies, and clinicians.
A clear read on competitors, pipelines, and the conversations shaping a therapy area.
Forecasts and valuations a leadership team can defend, from pipeline asset to supply plan.
Programs that combine practices around one commercial outcome.
AI tool · Decision Radar
Pick the decision in front of your team. The radar shows how PharmSight typically weights each practice for it. These weights are a guide written by the team, not a live model.
Launch: Forecasting and Competitive Intelligence lead, with RWE & HEOR close behind.
| Practice | Weight |
|---|
AI tool · Ask IntelliSight
This demo shows how IntelliSight answers. Choose a question to see a sample reply with a chart. Replies are scripted examples — nothing is sent anywhere.
Which region grew fastest this quarter?
The North region grew fastest, up 14% on the last quarter, driven mostly by new patient starts.
Based on: sales and patient-start data
Four tools built for pharma workflows.

Curated news, events, analyst insight, and historical sales in one landscape view.

AI role-play for negotiation and sales, including pricing and objection handling.

Ask commercial data a question and see the chart beside the answer.
Part of the proprietary AI toolkit. A public product screen has not been released yet.
The new brand strategy was supported by analysis done by PharmSight team.
Tell us the decision in front of you. This form stays in your browser — nothing is sent.